文献速递乳腺癌放疗放疗物理与技术

韩国放射肿瘤学组19-09乳腺癌多机构前瞻性队列研究的模拟运行质量保证研究

Dummy run quality assurance study in the Korean Radiation Oncology Group 19 - 09 multi-institutional prospective cohort study of breast cancer.
PubMed 文献 · Radiat Oncol · 2022-11-16

韩国放射肿瘤学组(KROG)19-09前瞻性队列研究旨在确定区域淋巴结照射对ypN0乳腺癌患者区域复发率的影响。12家参与机构针对2例模拟病例的CT图像、按4种临床场景制定放疗计划,并基于参考结构集分析剂量体积直方图。结果显示机构间和病例间的靶区与危及器官剂量存在差异,区域淋巴结区域尤为明显;全乳+区域淋巴结照射(WBI+RNI)计划的95%等剂量线机构间一致性低于全乳照射(WBI)计划(Fleiss kappa分别为0.731、0.679与0.830、0.767)。

要点

  • WBI+RNI计划95%等剂量线的机构间一致性低于WBI计划。
  • 大乳房和小乳房WBI计划的Fleiss kappa分别为0.830和0.767。
  • 大乳房和小乳房WBI+RNI计划的Fleiss kappa分别为0.731和0.679。

核心结论

  • 研究观察到各机构间及各病例间在靶区体积和危及器官所受辐射剂量上存在差异。
  • 由于KROG 19-09为前瞻性队列研究,研究者接受了不同机构间的剂量学差异。
  • 应收集实际患者的放疗计划数据,以获得可靠的KROG 19-09研究结果。

研究设计与样本

  • 韩国放射肿瘤学组(KROG)19-09为多机构前瞻性队列研究,旨在确定区域淋巴结照射对ypN0乳腺癌患者区域复发率的影响。
  • 12家参与机构使用2例模拟病例的计算机断层扫描图像,针对4种临床场景制定放疗计划。
  • 基于参考结构集,在收集放疗计划后分析剂量体积直方图。

主要发现

  • 各机构间的剂量分布存在差异,区域淋巴结区域尤为明显。
  • WBI+RNI计划在95%等剂量线上的机构间一致性和相似性低于WBI计划。
  • 大乳房WBI计划的Fleiss kappa值为0.830,小乳房WBI计划为0.767。
  • 大乳房WBI+RNI计划的Fleiss kappa值为0.731,小乳房WBI+RNI计划为0.679。
  • WBI计划中腋窝1站结构95%体积所受最小剂量(D95%)存在离群值,WBI+RNI计划中胸肌间区域和腋窝4站D95%存在离群值。

关键数值与推荐

  • 大乳房WBI计划95%等剂量线的Fleiss kappa值为0.830。
  • 小乳房WBI计划95%等剂量线的Fleiss kappa值为0.767。
  • 大乳房WBI+RNI计划95%等剂量线的Fleiss kappa值为0.731。
  • 小乳房WBI+RNI计划95%等剂量线的Fleiss kappa值为0.679。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Korean Radiation Oncology Group (KROG) 19 - 09 prospective cohort study aims to determine the effect of regional nodal irradiation on regional recurrence rates in ypN0 breast cancer patients. Dosimetric variations between radiotherapy (RT) plans of participating institutions may affect the clinical outcome of the study. We performed this study to assess inter-institutional dosimetric variations by dummy run. METHODS: Twelve participating institutions created RT plans for four clinical scenarios using computed tomography images of two dummy cases. Based on a reference structure set, we analyzed dose-volume histograms after collecting the RT plans. RESULTS: We found variations in dose distribution between institutions, especially in the regional nodal areas. Whole breast and regional nodal irradiation (WBI + RNI) plans had lower inter-institutional agreement and similarity for 95% isodose lines than WBI plans. Fleiss's kappa values, which were used to measure inter-institutional agreement for the 95% isodose lines, were 0.830 and 0.767 for the large and medium breast WBI plans, respectively, and 0.731 and 0.679 for the large and medium breast WBI + RNI plans, respectively. There were outliers in minimum dose delivered to 95% of the structure (D95%) of axillary level 1 among WBI plans and in D95% of the interpectoral region and axillary level 4 among WBI + RNI plans. CONCLUSION: We found inter-institutional and inter-case variations in radiation dose delivered to target volumes and organs at risk. As KROG 19 - 09 is a prospective cohort study, we accepted the dosimetric variation among the different institutions. Actual patient RT plan data should be collected to achieve reliable KROG 19 - 09 study results.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kim M, Park B, Kim H, et al. Dummy run quality assurance study in the Korean Radiation Oncology Group 19 - 09 multi-institutional prospective cohort study of breast cancer. Radiat Oncol. 2022. PMID: 36384804. doi:10.1186/s13014-022-02140-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。